Moderna
MRNA
#1262
Rank
S$19.10 B
Marketcap
$49.65
Share price
-0.94%
Change (1 day)
-52.99%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$19.10 Billion

As of November 2024 Moderna has a market cap of S$19.10 Billion. This makes Moderna the world's 1262th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024S$19.10 B-61.85%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Moderna was reported to be:

S$19.10 Billion
by Yahoo Finance info icon info icon
S$19.10 Billion
by CompaniesMarketCap info icon info icon
S$19.10 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$0.12 B-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
S$331.30 B 1,633.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.11 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$43.13 B 125.74%๐Ÿ‡บ๐Ÿ‡ธ USA
S$277.11 B 1,350.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$3.12 B-83.64%๐Ÿ‡บ๐Ÿ‡ธ USA
S$495.47 B 2,493.22%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.00 B-79.05%๐Ÿ‡บ๐Ÿ‡ธ USA